DeutschNewstral
Article
The Times of India on 2020-08-03 23:07
Serum gets DCGI nod for Phase 2 & 3 trials
Related news
- Serum gets DCGI nod for Phase 2 & 3 trialsThe Times of India
Serum Institute gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccineThe Hindu- Serum Institute gets DCGI nod to make Sputnik V in IndiaThe Hindu
- DCGI nod for Covaxin human trialsThe Hindu
- Serum gets notice for continuing vaccine trialsThe Times of India
- Oxford vaccine: DCGI directs Serum Institute of India to suspend recruitment for trialsThe Hindu
- Corbevax gets DCGI nod for use as booster jabThe Times of India
- COVID-19: DCGI nod to SII for phase 2 and 3 human clinical trials of Oxford vaccine candidateThe Hindu
- CIndia: Serum Institute’s COVID-19 vaccine goes into Phase-2/3 trialscychron.com
- COVISHIELD completes enrolment of Phase-3 clinical trials under partnership of ICMR, Serum Institute of IndiaThe Hindu
- Nod to Serum Institute for trials of Oxford vaccineThe Times of India
- India's first Covid-19 vaccine gets DCGI nodThe Times of India
- Serum Institute's Covovax vaccine gets WHO nodThe Times of India
- DCGI nod for Glenmark Pharma clinical trials on Favipiravir antiviral tablets for COVID-19 patientsThe Hindu
- DCGI gives nod to Bharat Biotech for intranasal booster dose trialsThe Hindu
- Bharat Biotech to submit trials' data to DCGI next weekThe Times of India
- Biocon’s psoriasis drug gets DCGI nod for use in COVID-19 patientsThe Hindu
- Bharat Biotech’s nasal COVID-19 vaccine gets nod for phase 2/3 trialThe Hindu